How RWD and AI Can Accelerate Drug Development for Common Cancers: Q&A with Dr. C.K. Wang - COTA Healthcare
We sat down with COTA’s Chief Medical Officer and oncologist, Dr. C.K. Wang, to discuss solid-tumor RWD – and how combining it with powerful artificial intelligence (AI) models will support drug development for people with cancer.| COTA Healthcare
